Skip to content

Early Weight Bearing Tarsometatarsal Fusion Study

A Prospective, Randomized, Controlled Trial Comparing Early Weight Bearing Versus Non-Weight Bearing Following Modified Lapidus Arthrodesis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03812237
Enrollment
131
Registered
2019-01-23
Start date
2012-01-20
Completion date
2017-12-01
Last updated
2019-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hallux Valgus

Keywords

Lapidus Arthrodesis, Early Weight Bearing, First Tarsometatarsal Arthrodesis

Brief summary

A Prospective, Randomized, Controlled Trial Comparing Early Weight Bearing versus Non Weight Bearing Following Modified Lapidus Arthrodesis

Detailed description

The purpose of this prospective randomized control trial is to assess outcomes in patients who undergo modified Lapidus arthrodesis and whose postoperative management includes early weight bearing on heel (in a boot) and compare it to standard of care non weight bearing post operative management.

Interventions

OTHER(EWB) Early Weight Bearing (2 Weeks Post-op)

Patient were permitted to progressively weightbear on their heel at 2 week post-op.

Sponsors

Grand Rapids Medical Education Partners
CollaboratorOTHER
Orthopaedic Associates of Michigan, PC
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

Patients were blinded to treatment until their 2 week post-operative visit.

Intervention model description

Prospective, Randomized, Controlled Trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patient has signed the Institutional Review Board approved informed consent form specific to this study prior to enrollment * Failure of conservative treatment (i.e. non-surgical action, consisting of footwear modification in the form of shoes with wide toe boxes, padded inserts, activity modifications and pain control medications) * Patients who underwent Lapidus procedure with or without other procedures of the first ray (i.e., muscle-tendon procedures, distal metatarsal osteotomy, Akin procedure) * Patient older than 18 years of age * Patient is able to give informed consent * Patient is independent, ambulatory, and agrees to comply with all postoperative visits

Exclusion criteria

* Patient has a pre-existing condition which may cause impairment of healing and bone fusion * Any significant pathology that, in the opinion of investigator, makes the patient unsuitable for study * Patients who underwent Lapidus arthrodesis in conjunction with other procedures that did not focus on the first pedal ray with the exception of harvesting autogenous ipsilateral calcaneal bone graft

Design outcomes

Primary

MeasureTime frameDescription
TMT Fusion Rate6 monthsTo compare the incidence and rate of first TMT fusion using two different postoperative protocols until fusion consolidation.

Secondary

MeasureTime frameDescription
Visual Analogue Scale (VAS)12 monthsAssessment of clinical/subjective feedback via questionnaires during the postoperative follow up period. VAS assessment: \[0 (no pain) - 10 (worse possible pain)\]
American Foot & Ankle Society Midfoot Scores (AOFAS)12 monthsAssessment of clinical/subjective feedback via questionnaires during the postoperative follow up period.\] AOFAS Scale: \[0 (no function/severe deformity) to 83 (full function/no limitations/deformity)\]
Short Musculoskeletal Function Assessment (SMFA)12 monthsAssessment of clinical/subjective feedback via questionnaires during the postoperative follow up period. SMFA Scale: 101 items scored 1 to 5 \[1( problems/no difficulty/not bothered) - 5 (unable to do task/symptoms constantly/extremely bothered)\]
Foot Function Index Revised (FFIr)12 monthsAssessment of clinical/subjective feedback via questionnaires during the postoperative follow up period. FFIr Scale: 67 items scored 1 to 7 \[1(no problems/no difficulty/not bothered) - 6 (unable to do a task/symptoms all the time/worst pain imaginable) - 7 (Not applicable)\]. Score range: 46 to 230.
Short Form Health Survey (SF-36) v.212 monthsAssessment of clinical/subjective feedback via questionnaires during the postoperative follow up period. SF-36 v.2 Scale: Self-reporting outcomes assessment \[0 (no function/severe physical/mental disability) to 100 (full function, no limitations to mental/physical health)\]. Score range: 46 to 230.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026